DISC-0974-102
Phase I/II
OPEN TO ACCRUAL
A Phase 1b/2a Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants with Myelofibrosis and Anemia
HMP-2020-306-GLOB1
Phase I
OPEN TO ACCRUAL *
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations